Friday, May 20, 2011

We, One Voice Against Cancer, called on Congress for the following "Asks." 5/23-/5/24 Lobby Day

OVAC FY 2012 Budget Priorities
OVAC recognizes the importance of federal funding for cancer research, early detection and prevention programs. OVAC also supports federal funding for programs that help cancer patients navigate the health care system and ensure a well-trained and adequately staffed nursing workforce.

OVAC is calling on Congress to:

1. Support funding for the National Institutes of Health, National Cancer Institute, and National Institute on Minority Health and Health Disparities. Ongoing cancer research is on the verge of making great progress in the prevention, detection, and treatment of cancer. This progress is in jeopardy absent sustained funding.

2. Support funding for the Centers for Disease Control cancer programs and keep these programs intact while other chronic diseases programs are potentially reorganized. These CDC state-based cancer programs provide vital resources for cancer surveillance, breast and cervical, and colorectal cancer screening, and awareness initiatives targeting skin, prostate, ovarian and blood cancers. Cuts in funding would reduce the number people being served by life-saving screening programs and outreach programs.

3. Support funding for the Health Resources and Services Administration (HRSA) Patient Navigator Program to help cancer patients navigate the health care system and overcome barriers to access cancer care. Support funding for the HRSA Title VIII Nursing Programs.

4. Support funding for the Food and Drug Administration to further integrate cutting-edge science that will streamline the translation of cancer research from early stage discovery to clinical application.

5. Support funding for the Caroline Pryce Walker Conquer Childhood Cancer Act. This funding would support the pediatric cancer programs at NCI, CDC, and the Department of Health and Human Services.

*My meetings were held with the offices of Lindsey Graham (S), Jim DeMint (S) and Jeff Duncan (H).